Literature DB >> 26379986

Whether inflammatory myofibroblastic tumor of the thigh relapses after surgical excision?

Hao Liu1, Jun Lin1, Peng Yang1, Hao Shen1, Huilin Yang1.   

Abstract

As reported previously, the 61-year-old male Chinese patient suffering from the inflammatory myofibroblastic tumor of the right thigh without bone involvement was performed a surgical excision and a local radiotherapy two years ago. However, a moderately soft and painful 200 × 100 mm mass of the posterior thigh, where magnetic resonance imaging (MRI) scans revealed an inhomogeneously hyperintense on T1-weighted imaging (T1WI), T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI), was found forty days after the operation. Two years into follow-up, we intend to judge whether the tumor relapses by regular imaging examination including thoracic computed tomography (CT) scans and local MRI scans of lower extremities. The diagnosis of postoperative cyst is suggested.

Entities:  

Keywords:  Inflammatory myofibroblastic tumor; magnetic resonance imaging; radiotherapy

Year:  2015        PMID: 26379986      PMCID: PMC4565369     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  11 in total

1.  Multiple intraosseous inflammatory myofibroblastic tumors presenting with an aggressive clinical course: case report.

Authors:  Yasuo Sasagawa; Takuya Akai; Shoutarou Itou; Hideaki Iizuka
Journal:  Neurosurgery       Date:  2011-10       Impact factor: 4.654

2.  Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences.

Authors:  L R Donner; R A Trompler; R R White
Journal:  Hum Pathol       Date:  1996-10       Impact factor: 3.466

3.  Improvement of inflammatory pseudotumor of the liver after nonsteroidal anti-inflammatory agent therapy.

Authors:  Y Hakozaki; M Katou; K Nakagawa; T Shirahama; T Matsumoto
Journal:  Am J Gastroenterol       Date:  1993-07       Impact factor: 10.864

4.  Plasma cell granuloma of the lung, response to radiation therapy: report of a single case.

Authors:  S V Hoover; A S Granston; D F Koch; T R Hudson
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

5.  Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor.

Authors:  Larisa V Debelenko; Diane C Arthur; Svetlana D Pack; Lee J Helman; David S Schrump; Maria Tsokos
Journal:  Lab Invest       Date:  2003-09       Impact factor: 5.662

6.  Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases.

Authors:  C M Coffin; J Watterson; J R Priest; L P Dehner
Journal:  Am J Surg Pathol       Date:  1995-08       Impact factor: 6.394

7.  Inflammatory myofibroblastic tumors in childhood: a report from the Italian Cooperative Group studies.

Authors:  Rita Alaggio; Giovanni Cecchetto; Gianni Bisogno; Claudio Gambini; Maria Luisa Calabrò; Alessandro Inserra; Renata Boldrini; Gian Luca De Salvo; Emanuele S G d'Amore; Patrizia Dall'igna
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

8.  Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.

Authors:  Cheryl M Coffin; Jason L Hornick; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

9.  Inflammatory myofibroblastic tumor of the temporal bone.

Authors:  Roberto Gasparotti; Diego Zanetti; Andrea Bolzoni; Paola Gamba; Maria L Morassi; Marco Ungari
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

10.  Inflammatory myofibroblastic tumor of the thigh without bone involvement: a case report.

Authors:  Jun Lin; Hao Liu; Yin Zhuang; Peng Yang; Yifei Zheng; Yan Yang; Huilin Yang
Journal:  World J Surg Oncol       Date:  2014-07-15       Impact factor: 2.754

View more
  1 in total

1.  Clinical characteristics and outcomes of 17 cases of inflammatory myofibroblastic tumor at a University Hospital in China.

Authors:  Wei Song; Yan Zhu
Journal:  Oncol Lett       Date:  2020-11-18       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.